Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017, Article ID 5762172, 18 pages
https://doi.org/10.1155/2017/5762172
Review Article

Antidepressant Flavonoids and Their Relationship with Oxidative Stress

1Department of Biology, Alexandru Ioan Cuza University of Iasi, Bd. Carol I No. 11, 700506 Iasi, Romania
2Department of Pharmaceutical Chemistry, M. M. College of Pharmacy, Mullana, Maharishi Markandeshwar University, Ambala, Haryana 133203, India
3Department of Molecular Biology and Genetics, Erzurum Technical University, 25000 Erzurum, Turkey
4Departamento de Farmácia, Universidade Federal de Sergipe, 49100-000 São Cristóvão, SE, Brazil
5Departamento de Ciências Farmacêuticas, Universidade Federal da Paraíba, 58051-970 João Pessoa, PB, Brazil

Correspondence should be addressed to Damião Pergentino de Sousa; rb.moc.oohay@asuosed_oaimad

Received 7 September 2017; Accepted 22 November 2017; Published 19 December 2017

Academic Editor: Kota V. Ramana

Copyright © 2017 Lucian Hritcu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Z. Guo, X. Liu, H. Hou, F. Wei, J. Liu, and X. Chen, “Abnormal degree centrality in Alzheimer’s disease patients with depression: a resting-state functional magnetic resonance imaging study,” Experimental Gerontology, vol. 79, pp. 61–66, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Chi, C. Wang, T. Jiang, X. C. Zhu, J. T. Yu, and L. Tan, “The prevalence of depression in Alzheimer’s disease: a systematic review and meta-analysis,” Current Alzheimer Research, vol. 12, no. 2, pp. 189–198, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Naudin and B. Atanasova, “Olfactory markers of depression and Alzheimer’s disease,” Neuroscience & Biobehavioral Reviews, vol. 45, pp. 262–270, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. V. Krishnan and E. J. Nestler, “The molecular neurobiology of depression,” Nature, vol. 455, no. 7215, pp. 894–902, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. C. Li, J. D. Shen, J. Li, R. Wang, S. Jiao, and L. T. Yi, “Chronic treatment with baicalin prevents the chronic mild stress-induced depressive-like behavior: involving the inhibition of cyclooxygenase-2 in rat brain,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 40, pp. 138–143, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Wuwongse, R. C. C. Chang, and A. C. K. Law, “The putative neurodegenerative links between depression and Alzheimer’s disease,” Progress in Neurobiology, vol. 91, no. 4, pp. 362–375, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. P. J. Seignourel, M. E. Kunik, L. Snow, N. Wilson, and M. Stanley, “Anxiety in dementia: a critical review,” Clinical Psychology Review, vol. 28, no. 7, pp. 1071–1082, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. S. E. Starkstein, R. Mizrahi, and B. D. Power, “Depression in Alzheimer’s disease: phenomenology, clinical correlates and treatment,” International Review of Psychiatry, vol. 20, no. 4, pp. 382–388, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Ammendola and C. Kornreich, “Are antidepressants really effective?” Revue Medicale de Bruxelles, vol. 36, no. 5, pp. 421–429, 2015. View at Google Scholar
  10. L. P. Guan and B. Y. Liu, “Antidepressant-like effects and mechanisms of flavonoids and related analogues,” European Journal of Medicinal Chemistry, vol. 121, pp. 47–57, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. M. E. Thase, “Evaluating antidepressant therapies: remission as the optimal outcome,” The Journal of Clinical Psychiatry, vol. 64, pp. 18–25, 2003. View at Google Scholar
  12. D. D. Mousseau and G. B. Baker, “Recent developments in the regulation of monoamine oxidase form and function: is the current model restricting our understanding of the breadth of contribution of monoamine oxidase to brain [dys]function?” Current Topics in Medicinal Chemistry, vol. 12, no. 20, pp. 2163–2176, 2012. View at Publisher · View at Google Scholar
  13. X. Cao, L. Rui, P. R. Pennington et al., “Serine 209 resides within a putative p38(MAPK) consensus motif and regulates monoamine oxidase-A activity,” Journal of Neurochemistry, vol. 111, no. 1, pp. 101–110, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. C. S. Lam, J. J. Li, G. L. Tipoe, M. B. H. Youdim, and M. L. Fung, “Monoamine oxidase A upregulated by chronic intermittent hypoxia activates indoleamine 2,3-dioxygenase and neurodegeneration,” PLoS One, vol. 12, no. 6, article e0177940, 2017. View at Publisher · View at Google Scholar
  15. Q. Q. Mao, S. P. Ip, K. M. Ko, S. H. Tsai, Y. F. Xian, and C. T. Che, “Effects of peony glycosides on mice exposed to chronic unpredictable stress: further evidence for antidepressant-like activity,” Journal of Ethnopharmacology, vol. 124, no. 2, pp. 316–320, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. A. E. S. El-Tarras, H. F. Attia, M. M. Soliman, M. A. El Awady, and A. A. Amin, “Neuroprotective effect of grape seed extract against cadmium toxicity in male albino rats,” International Journal of Immunopathology and Pharmacology, vol. 29, no. 3, pp. 398–407, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Riederer and T. Müller, “Use of monoamine oxidase inhibitors in chronic neurodegeneration,” Expert Opinion on Drug Metabolism & Toxicology, vol. 13, no. 2, pp. 233–240, 2017. View at Publisher · View at Google Scholar
  18. P. Czarny, P. Wigner, P. Galecki, and T. Sliwinski, “The interplay between inflammation, oxidative stress, DNA damage, DNA repair and mitochondrial dysfunction in depression,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 80, Part C, pp. 309–321, 2018. View at Publisher · View at Google Scholar
  19. T. Huang, F. Zhou, F. Wang-Johanning, K. Nan, and Y. Wei, “Depression accelerates the development of gastric cancer through reactive oxygen species-activated ABL1 (review),” Oncology Reports, vol. 36, no. 5, pp. 2435–2443, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Kruk and H. Y. Aboul-Enein, “Reactive oxygen and nitrogen species in carcinogenesis: implications of oxidative stress on the progression and development of several cancer types,” Mini Reviews in Medicinal Chemistry, vol. 17, no. 11, pp. 904–919, 2017. View at Publisher · View at Google Scholar
  21. Z. J. Zhang, “Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders,” Life Sciences, vol. 75, no. 14, pp. 1659–1699, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. R. C. Ekeanyanwu and O. U. Njoku, “Flavonoid-rich fraction of the MonoMonodora tenuifolia seed extract attenuates behavioural alterations and oxidative damage in forced-swim stressed rats,” Chinese Journal of Natural Medicines, vol. 13, no. 3, pp. 183–191, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Herrera-Ruiz, A. Zamilpa, M. González-Cortazar et al., “Antidepressant effect and pharmacological evaluation of standardized extract of flavonoids from Byrsonima crassifolia,” Phytomedicine, vol. 18, no. 14, pp. 1255–1261, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Sun, H. Wang, B. Liu et al., “Rutin attenuates H2O2-induced oxidation damage and apoptosis in Leydig cells by activating PI3K/Akt signal pathways,” Biomedicine & Pharmacotherapy, vol. 88, pp. 500–506, 2017. View at Publisher · View at Google Scholar
  25. S. Kanimozhi, P. Bhavani, and P. Subramanian, “Influence of the flavonoid, quercetin on antioxidant status, lipid peroxidation and histopathological changes in hyperammonemic rats,” Indian Journal of Clinical Biochemistry, vol. 32, no. 3, pp. 275–284, 2017. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Ahmadi and A. Shadboorestan, “Oxidative stress and cancer; the role of hesperidin, a citrus natural bioflavonoid, as a cancer chemoprotective agent,” Nutrition and Cancer, vol. 68, no. 1, pp. 29–39, 2016. View at Publisher · View at Google Scholar · View at Scopus
  27. Z. Liu, T. Zhou, A. C. Ziegler, P. Dimitrion, and L. Zuo, “Oxidative stress in neurodegenerative diseases: from molecular mechanisms to clinical applications,” Oxidative Medicine and Cellular Longevity, vol. 2017, Article ID 2525967, 11 pages, 2017. View at Publisher · View at Google Scholar
  28. S. Salim, “Oxidative stress and the central nervous system,” The Journal of Pharmacology and Experimental Therapeutics, vol. 360, no. 1, pp. 201–205, 2017. View at Publisher · View at Google Scholar
  29. M. Vaváková, Z. Ďuračková, and J. Trebatická, “Markers of oxidative stress and neuroprogression in depression disorder,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 898393, 12 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. D. Filipović, N. Todorović, R. E. Bernardi, and P. Gass, “Oxidative and nitrosative stress pathways in the brain of socially isolated adult male rats demonstrating depressive- and anxiety-like symptoms,” Brain Structure and Function, vol. 222, no. 1, pp. 1–20, 2017. View at Publisher · View at Google Scholar · View at Scopus
  31. P. K. Maurya, C. Noto, L. B. Rizzo et al., “The role of oxidative and nitrosative stress in accelerated aging and major depressive disorder,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 65, pp. 134–144, 2016. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Pláteník, Z. Fišar, R. Buchal et al., “GSK3β, CREB, and BDNF in peripheral blood of patients with Alzheimer’s disease and depression,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 50, pp. 83–93, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Y. Zheleznyakova, H. Cao, and H. B. Schiöth, “BDNF DNA methylation changes as a biomarker of psychiatric disorders: literature review and open access database analysis,” Behavioral and Brain Functions, vol. 12, no. 1, p. 17, 2016. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Tanila, “The role of BDNF in Alzheimer’s disease,” Neurobiology of Disease, vol. 97, Part B, pp. 114–118, 2017. View at Publisher · View at Google Scholar
  35. S. T. Ahmad, W. Arjumand, S. Nafees et al., “Hesperidin alleviates acetaminophen induced toxicity in Wistar rats by abrogation of oxidative stress, apoptosis and inflammation,” Toxicology Letters, vol. 208, no. 2, pp. 149–161, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. H.-L. Yang, S.-C. Chen, K. J. Senthil Kumar et al., “Antioxidant and anti-inflammatory potential of hesperetin metabolites obtained from hesperetin-administered rat serum: an ex vivo approach,” Journal of Agricultural and Food Chemistry, vol. 60, no. 1, pp. 522–532, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. S. L. Hwang and G. C. Yen, “Neuroprotective effects of the citrus flavanones against H2O2-induced cytotoxicity in PC12 cells,” Journal of Agricultural and Food Chemistry, vol. 56, no. 3, pp. 859–864, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. K. H. Lee, M. H. Yeh, S. T. Kao et al., “The inhibitory effect of hesperidin on tumor cell invasiveness occurs via suppression of activator protein 1 and nuclear factor-kappaB in human hepatocellular carcinoma cells,” Toxicology Letters, vol. 194, no. 1-2, pp. 42–49, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. S. A. El-Marasy, H. M. I. Abdallah, S. M. El-Shenawy, A. S. El-Khatib, O. A. El-Shabrawy, and S. A. Kenawy, “Anti-depressant effect of hesperidin in diabetic rats,” Canadian Journal of Physiology and Pharmacology, vol. 92, no. 11, pp. 945–952, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. F. Donato, M. G. de Gomes, A. T. R. Goes et al., “Hesperidin exerts antidepressant-like effects in acute and chronic treatments in mice: possible role of L-arginine-NO-cGMP pathway and BDNF levels,” Brain Research Bulletin, vol. 104, pp. 19–26, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. C.-F. Li, S.-M. Chen, X.-M. Chen et al., “ERK-dependent brain-derived neurotrophic factor regulation by hesperidin in mice exposed to chronic mild stress,” Brain Research Bulletin, vol. 124, pp. 40–47, 2016. View at Publisher · View at Google Scholar · View at Scopus
  42. H. Cho, C. W. Yun, W. K. Park et al., “Modulation of the activity of pro-inflammatory enzymes, COX-2 and iNOS, by chrysin derivatives,” Pharmacological Research, vol. 49, no. 1, pp. 37–43, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Lapidot, M. D. Walker, and J. Kanner, “Antioxidant and prooxidant effects of phenolics on pancreatic β-cells in vitro,” Journal of Agricultural and Food Chemistry, vol. 50, no. 25, pp. 7220–7225, 2002. View at Publisher · View at Google Scholar · View at Scopus
  44. M. S. Zarzecki, S. M. Araujo, V. C. Bortolotto, M. T. de Paula, C. R. Jesse, and M. Prigol, “Hypolipidemic action of chrysin on triton WR-1339-induced hyperlipidemia in female C57BL/6 mice,” Toxicology Reports, vol. 1, pp. 200–208, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. C. B. Filho, C. R. Jesse, F. Donato et al., “Chronic unpredictable mild stress decreases BDNF and NGF levels and Na+,K+-ATPase activity in the hippocampus and prefrontal cortex of mice: antidepressant effect of chrysin,” Neuroscience, vol. 289, pp. 367–380, 2015. View at Publisher · View at Google Scholar · View at Scopus
  46. C. B. Filho, C. R. Jesse, F. Donato et al., “Chrysin promotes attenuation of depressive-like behavior and hippocampal dysfunction resulting from olfactory bulbectomy in mice,” Chemico-Biological Interactions, vol. 260, pp. 154–162, 2016. View at Publisher · View at Google Scholar · View at Scopus
  47. C. B. Filho, C. R. Jesse, F. Donato et al., “Neurochemical factors associated with the antidepressant-like effect of flavonoid chrysin in chronically stressed mice,” European Journal of Pharmacology, vol. 791, pp. 284–296, 2016. View at Publisher · View at Google Scholar · View at Scopus
  48. T. Baluchnejadmojarad and M. Roghani, “Effect of naringenin on intracerebroventricular streptozotocin-induced cognitive deficits in rat: a behavioral analysis,” Pharmacology, vol. 78, no. 4, pp. 193–197, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. H. T. Olsen, G. I. Stafford, J. van Staden, S. B. Christensen, and A. K. Jäger, “Isolation of the MAO-inhibitor naringenin from Mentha aquatica L,” Journal of Ethnopharmacology, vol. 117, no. 3, pp. 500–502, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. V. P. Muthaiah, L. Venkitasamy, F. M. Michael, K. Chandrasekar, and S. Venkatachalam, “Neuroprotective role of naringenin on carbaryl induced neurotoxicity in mouse neuroblastoma cells,” Journal of Pharmacology & Pharmacotherapeutics, vol. 4, no. 3, pp. 192–197, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. L. T. Yi, B. B. Liu, J. Li et al., “BDNF signaling is necessary for the antidepressant-like effect of naringenin,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 48, pp. 135–141, 2014. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Naqinezhad, S. Nabavi, S. Nabavi, and M. Ebrahimzadeh, “Antioxidant and antihemolytic activities of flavonoid rich fractions of Artemisia tschernieviana Besser,” European Review for Medical and Pharmacological Sciences, vol. 16, Supplement 3, pp. 88–94, 2012. View at Google Scholar
  53. F. Petacci, S. S. Freitas, I. L. Brunetti, and N. M. Khalil, “Inhibition of peroxidase activity and scavenging of reactive oxygen species by astilbin isolated from Dimorphandra mollis (Fabaceae, Caesalpinioideae),” Biological Research, vol. 43, no. 1, pp. 63–74, 2010. View at Publisher · View at Google Scholar
  54. Q. Q. Lv, W. J. Wu, X. L. Guo et al., “Antidepressant activity of astilbin: involvement of monoaminergic neurotransmitters and BDNF signal pathway,” Biological and Pharmaceutical Bulletin, vol. 37, no. 6, pp. 987–995, 2014. View at Publisher · View at Google Scholar · View at Scopus
  55. X. Wu, J. Wu, S. Xia, B. Li, and J. Dong, “Icaritin opposes the development of social aversion after defeat stress via increases of GR mRNA and BDNF mRNA in mice,” Behavioural Brain Research, vol. 256, pp. 602–608, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. B. Liu, C. Xu, X. Wu et al., “Icariin exerts an antidepressant effect in an unpredictable chronic mild stress model of depression in rats and is associated with the regulation of hippocampal neuroinflammation,” Neuroscience, vol. 294, pp. 193–205, 2015. View at Publisher · View at Google Scholar · View at Scopus
  57. K. Wei, Y. Xu, Z. Zhao et al., “Icariin alters the expression of glucocorticoid receptor, FKBP5 and SGK1 in rat brains following exposure to chronic mild stress,” International Journal of Molecular Medicine, vol. 38, no. 1, pp. 337–344, 2016. View at Publisher · View at Google Scholar · View at Scopus
  58. X. Liu, Q. Qi, G. Xiao, J. Li, H. R. Luo, and K. Ye, “O-methylated metabolite of 7,8-dihydroxyflavone activates TrkB receptor and displays antidepressant activity,” Pharmacology, vol. 91, no. 3-4, pp. 185–200, 2013. View at Publisher · View at Google Scholar · View at Scopus
  59. S.-W. Jang, X. Liu, M. Yepes et al., “A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone,” Proceedings of the National Academy of Sciences, vol. 107, no. 6, pp. 2687–2692, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. X. Liu, C. B. Chan, S. W. Jang et al., “A synthetic 7,8-dihydroxyflavone derivative promotes neurogenesis and exhibits potent antidepressant effect,” Journal of Medicinal Chemistry, vol. 53, no. 23, pp. 8274–8286, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Zheng, C. Liu, F. Pan, D. Shi, and Y. Zhang, “Antidepressant-like effect of hyperoside isolated from Apocynum venetum leaves: possible cellular mechanisms,” Phytomedicine, vol. 19, no. 2, pp. 145–149, 2012. View at Publisher · View at Google Scholar · View at Scopus
  62. J. S. Haas, E. D. Stolz, A. H. Betti et al., “The anti-immobility effect of hyperoside on the forced swimming test in rats is mediated by the D2-like receptors activation,” Planta Medica, vol. 77, no. 4, pp. 334–339, 2011. View at Publisher · View at Google Scholar · View at Scopus
  63. C. Liu, J. Wu, J. Gu et al., “Baicalein improves cognitive deficits induced by chronic cerebral hypoperfusion in rats,” Pharmacology Biochemistry and Behavior, vol. 86, no. 3, pp. 423–430, 2007. View at Publisher · View at Google Scholar · View at Scopus
  64. D. E. Shieh, L. T. Liu, and C. C. Lin, “Antioxidant and free radical scavenging effects of baicalein, baicalin and wogonin,” Anticancer Research, vol. 20, no. 5A, pp. 2861–2865, 2000. View at Google Scholar
  65. Z. Xiong, B. Jiang, P. F. Wu et al., “Antidepressant effects of a plant-derived flavonoid baicalein involving extracellular signal-regulated kinases cascade,” Biological and Pharmaceutical Bulletin, vol. 34, no. 2, pp. 253–259, 2011. View at Publisher · View at Google Scholar · View at Scopus
  66. L. F. Li, J. Yang, S. P. Ma, and R. Qu, “Magnolol treatment reversed the glial pathology in an unpredictable chronic mild stress-induced rat model of depression,” European Journal of Pharmacology, vol. 711, no. 1–3, pp. 42–49, 2013. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Nakajima, M. Ogawa, Y. Amakura, M. Yoshimura, S. Okuyama, and Y. Furukawa, “3,5,6,7,8,3,4-Heptamethoxyflavone reduces interleukin-4 production in the spleen cells of mice,” Biomedical Research, vol. 37, no. 2, pp. 95–99, 2016. View at Publisher · View at Google Scholar · View at Scopus
  68. S. Okuyama, M. Morita, K. Miyoshi et al., “3,5,6,7,8,3,4-Heptamethoxyflavone, a citrus flavonoid, on protection against memory impairment and neuronal cell death in a global cerebral ischemia mouse model,” Neurochemistry International, vol. 70, pp. 30–38, 2014. View at Publisher · View at Google Scholar · View at Scopus
  69. A. Sawamoto, S. Okuyama, K. Yamamoto et al., “3,5,6,7,8,3,4-Heptamethoxyflavone, a citrus flavonoid, ameliorates corticosterone-induced depression-like behavior and restores brain-derived neurotrophic factor expression, neurogenesis, and neuroplasticity in the hippocampus,” Molecules, vol. 21, pp. 1–13, 2016. View at Publisher · View at Google Scholar · View at Scopus
  70. C. Grosso, P. Valentão, and P. B. Andrade, “Depressive disorders: prevalence, costs, and theories,” in Herbal Medicine in Depression: Traditional Medicine to Innovative Drug Delivery, C. Grosso, Ed., pp. 1–41, Springer International Publishing, Cham, 2016. View at Publisher · View at Google Scholar
  71. S. Jeon and Y. K. Kim, “Molecular neurobiology and promising new treatment in depression,” International Journal of Molecular Sciences, vol. 17, no. 3, p. 381, 2016. View at Publisher · View at Google Scholar · View at Scopus
  72. M. Freitas, D. Ribeiro, S. M. Tomé, A. M. S. Silva, and E. Fernandes, “Synthesis of chlorinated flavonoids with anti-inflammatory and pro-apoptotic activities in human neutrophils,” European Journal of Medicinal Chemistry, vol. 86, pp. 153–164, 2014. View at Publisher · View at Google Scholar · View at Scopus
  73. L. H. Mai, G. G. Chabot, P. Grellier et al., “Antivascular and anti-parasite activities of natural and hemisynthetic flavonoids from New Caledonian Gardenia species (Rubiaceae),” European Journal of Medicinal Chemistry, vol. 93, pp. 93–100, 2015. View at Publisher · View at Google Scholar · View at Scopus
  74. J. Cassani, A. Dorantes-Barrón, L. Novales, G. Real, and R. Estrada-Reyes, “Anti-depressant-like effect of kaempferitrin isolated from Justicia spicigera Schltdl (Acanthaceae) in two behavior models in mice: evidence for the involvement of the serotonergic system,” Molecules, vol. 19, no. 12, pp. 21442–21461, 2014. View at Publisher · View at Google Scholar · View at Scopus
  75. B. Du, X. Tang, F. Liu et al., “Antidepressant-like effects of the hydroalcoholic extracts of Hemerocallis citrina and its potential active components,” BMC Complementary and Alternative Medicine, vol. 14, no. 1, 2014. View at Publisher · View at Google Scholar · View at Scopus
  76. D. G. Machado, L. E. B. Bettio, M. P. Cunha et al., “Antidepressant-like effect of rutin isolated from the ethanolic extract from Schinus molle L. in mice: evidence for the involvement of the serotonergic and noradrenergic systems,” European Journal of Pharmacology, vol. 587, no. 1–3, pp. 163–168, 2008. View at Publisher · View at Google Scholar · View at Scopus
  77. L. C. Souza, M. G. de Gomes, A. T. R. Goes et al., “Evidence for the involvement of the serotonergic 5-HT1A receptors in the antidepressant-like effect caused by hesperidin in mice,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 40, pp. 103–109, 2013. View at Publisher · View at Google Scholar · View at Scopus
  78. C. B. Filho, L. Del Fabbro, M. G. de Gomes et al., “Kappa-opioid receptors mediate the antidepressant-like activity of hesperidin in the mouse forced swimming test,” European Journal of Pharmacology, vol. 698, no. 1–3, pp. 286–291, 2013. View at Publisher · View at Google Scholar · View at Scopus
  79. M. Ishisaka, K. Kakefuda, M. Yamauchi et al., “Luteolin shows an antidepressant-like effect via suppressing endoplasmic reticulum stress,” Biological and Pharmaceutical Bulletin, vol. 34, no. 9, pp. 1481–1486, 2011. View at Publisher · View at Google Scholar · View at Scopus
  80. J. B. I. De la Peña, C. A. Kim, H. L. Lee et al., “Luteolin mediates the antidepressant-like effects of Cirsium japonicum in mice, possibly through modulation of the GABAA receptor,” Archives of Pharmacal Research, vol. 37, no. 2, pp. 263–269, 2014. View at Publisher · View at Google Scholar · View at Scopus
  81. O. D. Can, U. Demir Ozkay, and U. I. Uçel, “Anti-depressant-like effect of vitexin in BALB/c mice and evidence for the involvement of monoaminergic mechanisms,” European Journal of Pharmacology, vol. 699, no. 1–3, pp. 250–257, 2013. View at Publisher · View at Google Scholar · View at Scopus
  82. J. P. Kim, I. S. Lee, J. J. Seo et al., “Vitexin, orientin and other flavonoids from Spirodela polyrhiza inhibit adipogenesis in 3T3-L1 cells,” Phytotherapy Research, vol. 24, no. 10, pp. 1543–1548, 2010. View at Publisher · View at Google Scholar · View at Scopus
  83. F. U. Afifi and R. Abu-Dahab, “Phytochemical screening and biological activities of Eminium spiculatum (Blume) Kuntze (family Araceae),” Natural Product Research, vol. 26, no. 9, pp. 878–882, 2012. View at Publisher · View at Google Scholar · View at Scopus
  84. H. Li, F. Song, J. Xing, R. Tsao, Z. Liu, and S. Liu, “Screening and structural characterization of α-glucosidase inhibitors from hawthorn leaf flavonoids extract by ultrafiltration LC-DAD-MSn and SORI-CID FTICR MS,” Journal of the American Society for Mass Spectrometry, vol. 20, no. 8, pp. 1496–1503, 2009. View at Publisher · View at Google Scholar · View at Scopus
  85. S. Perveen, A. M. El-Shafae, A. Al-Taweel et al., “Antioxidant and urease inhibitory C-glycosylflavonoids from Celtis africana,” Journal of Asian Natural Products Research, vol. 13, no. 9, pp. 799–804, 2011. View at Publisher · View at Google Scholar · View at Scopus
  86. Y. Zhou, Y. E. Liu, J. Cao et al., “Vitexins, nature-derived lignan compounds, induce apoptosis and suppress tumor growth,” Clinical Cancer Research, vol. 15, no. 16, pp. 5161–5169, 2009. View at Publisher · View at Google Scholar · View at Scopus
  87. X. Peng, Z. Zheng, K. W. Cheng et al., “Inhibitory effect of mung bean extract and its constituents vitexin and isovitexin on the formation of advanced glycation endproducts,” Food Chemistry, vol. 106, no. 2, pp. 475–481, 2008. View at Publisher · View at Google Scholar · View at Scopus
  88. M. Prabhakar, H. Bano, I. Kumar, M. Shamsi, and S. Khan, “Pharmacological investigations on vitexin,” Planta Medica, vol. 43, no. 12, pp. 396–403, 1981. View at Publisher · View at Google Scholar
  89. S. Gorzalczany, C. Marrassini, J. Miño, C. Acevedo, and G. Ferraro, “Antinociceptive activity of ethanolic extract and isolated compounds of Urtica circularis,” Journal of Ethnopharmacology, vol. 134, no. 3, pp. 733–738, 2011. View at Publisher · View at Google Scholar · View at Scopus
  90. D. H. Shin, Y. C. Bae, J. S. Kim-Han et al., “Polyphenol amentoflavone affords neuroprotection against neonatal hypoxic-ischemic brain damage via multiple mechanisms,” Journal of Neurochemistry, vol. 96, no. 2, pp. 561–572, 2006. View at Publisher · View at Google Scholar · View at Scopus
  91. I. O. Ishola, M. Chatterjee, S. Tota et al., “Antidepressant and anxiolytic effects of amentoflavone isolated from Cnestis ferruginea in mice,” Pharmacology Biochemistry and Behavior, vol. 103, no. 2, pp. 322–331, 2012. View at Publisher · View at Google Scholar · View at Scopus
  92. V. Zbarsky, K. P. Datla, S. Parkar, D. K. Rai, O. I. Aruoma, and D. T. Dexter, “Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson’s disease,” Free Radical Research, vol. 39, no. 10, pp. 1119–1125, 2005. View at Publisher · View at Google Scholar · View at Scopus
  93. L. T. Yi, C. F. Li, X. Zhan et al., “Involvement of monoaminergic system in the antidepressant-like effect of the flavonoid naringenin in mice,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 34, no. 7, pp. 1223–1228, 2010. View at Publisher · View at Google Scholar · View at Scopus
  94. L. T. Yi, J. Li, H. C. Li et al., “Antidepressant-like behavioral, neurochemical and neuroendocrine effects of naringenin in the mouse repeated tail suspension test,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 39, no. 1, pp. 175–181, 2012. View at Publisher · View at Google Scholar · View at Scopus
  95. K. Ishige, D. Schubert, and Y. Sagara, “Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms,” Free Radical Biology & Medicine, vol. 30, no. 4, pp. 433–446, 2001. View at Publisher · View at Google Scholar · View at Scopus
  96. D. E. Brash and P. A. Havre, “New careers for antioxidants,” Proceedings of the National Academy of Sciences, vol. 99, no. 22, pp. 13969–13971, 2002. View at Publisher · View at Google Scholar · View at Scopus
  97. L. Zhen, J. Zhu, X. Zhao et al., “The antidepressant-like effect of fisetin involves the serotonergic and noradrenergic system,” Behavioural Brain Research, vol. 228, no. 2, pp. 359–366, 2012. View at Publisher · View at Google Scholar · View at Scopus
  98. X. Yu, X. Jiang, X. Zhang et al., “The effects of fisetin on lipopolysaccharide-induced depressive-like behavior in mice,” Metabolic Brain Disease, vol. 31, no. 5, pp. 1011–1021, 2016. View at Publisher · View at Google Scholar · View at Scopus
  99. K. Matsuzaki, T. Yamakuni, M. Hashimoto et al., “Nobiletin restoring β-amyloid-impaired CREB phosphorylation rescues memory deterioration in Alzheimer’s disease model rats,” Neuroscience Letters, vol. 400, no. 3, pp. 230–234, 2006. View at Publisher · View at Google Scholar · View at Scopus
  100. H. Onozuka, A. Nakajima, K. Matsuzaki et al., “Nobiletin, a citrus flavonoid, improves memory impairment and Aβ pathology in a transgenic mouse model of Alzheimer’s disease,” Journal of Pharmacology and Experimental Therapeutics, vol. 326, no. 3, pp. 739–744, 2008. View at Publisher · View at Google Scholar · View at Scopus
  101. Y. Yamamoto, N. Shioda, F. Han et al., “Nobiletin improves brain ischemia-induced learning and memory deficits through stimulation of CaMKII and CREB phosphorylation,” Brain Research, vol. 1295, pp. 218–229, 2009. View at Publisher · View at Google Scholar · View at Scopus
  102. L. T. Yi, H. L. Xu, J. Feng, X. Zhan, L. P. Zhou, and C. C. Cui, “Involvement of monoaminergic systems in the antidepressant-like effect of nobiletin,” Physiology & Behavior, vol. 102, no. 1, pp. 1–6, 2011. View at Publisher · View at Google Scholar · View at Scopus
  103. A. Kahraman, H. Çakar, and T. Köken, “The protective effect of quercetin on long-term alcohol consumption-induced oxidative stress,” Molecular Biology Reports, vol. 39, no. 3, pp. 2789–2794, 2012. View at Publisher · View at Google Scholar · View at Scopus
  104. A. W. Boots, G. R. M. M. Haenen, and A. Bast, “Health effects of quercetin: from antioxidant to nutraceutical,” European Journal of Pharmacology, vol. 585, no. 2-3, pp. 325–337, 2008. View at Publisher · View at Google Scholar · View at Scopus
  105. E. A. Demir, H. S. Gergerlioglu, and M. Oz, “Antidepressant-like effects of quercetin in diabetic rats are independent of hypothalamic–pituitary–adrenal axis,” Acta Neuropsychiatrica, vol. 28, no. 1, pp. 23–30, 2016. View at Publisher · View at Google Scholar · View at Scopus
  106. S. Scheggi, A. Marandino, D. Del Monte et al., “The protective effect of Hypericum connatum on stress-induced escape deficit in rat is related to its flavonoid content,” Pharmaceutical Biology, vol. 54, no. 9, pp. 1782–1792, 2016. View at Publisher · View at Google Scholar · View at Scopus
  107. P. Rinwa and A. Kumar, “Quercetin suppress microglial neuroinflammatory response and induce antidepressent-like effect in olfactory bulbectomized rats,” Neuroscience, vol. 255, pp. 86–98, 2013. View at Publisher · View at Google Scholar · View at Scopus
  108. B. Singh, D. Singh, and R. K. Goel, “Dual protective effect of Passiflora incarnata in epilepsy and associated post-ictal depression,” Journal of Ethnopharmacology, vol. 139, no. 1, pp. 273–279, 2012. View at Publisher · View at Google Scholar · View at Scopus
  109. F. Donato, C. B. Filho, R. Giacomeli et al., “Evidence for the involvement of potassium channel inhibition in the antidepressant-like effects of hesperidin in the tail suspension test in mice,” Journal of Medicinal Food, vol. 18, no. 7, pp. 818–823, 2015. View at Publisher · View at Google Scholar · View at Scopus
  110. M. S. Antunes, C. R. Jesse, J. R. Ruff et al., “Hesperidin reverses cognitive and depressive disturbances induced by olfactory bulbectomy in mice by modulating hippocampal neurotrophins and cytokine levels and acetylcholinesterase activity,” European Journal of Pharmacology, vol. 789, pp. 411–420, 2016. View at Publisher · View at Google Scholar · View at Scopus
  111. Y. Z. Zhou, X. Li, W. X. Gong et al., “Protective effect of isoliquiritin against corticosterone-induced neurotoxicity in PC12 cells,” Food & Function, vol. 8, no. 3, pp. 1235–1244, 2017. View at Publisher · View at Google Scholar
  112. C. F. Ortmann, H. M. Abelaira, G. Z. Réus et al., “LC/QTOF profile and preliminary stability studies of an enriched flavonoid fraction of Cecropia pachystachya Trécul leaves with potential antidepressant-like activity,” Biomedical Chromatography, vol. 31, no. 11, 2017. View at Publisher · View at Google Scholar
  113. Y. Bandaruk, R. Mukai, T. Kawamura, H. Nemoto, and J. Terao, “Evaluation of the inhibitory effects of quercetin-related flavonoids and tea catechins on the monoamine oxidase-A reaction in mouse brain mitochondria,” Journal of Agricultural and Food Chemistry, vol. 60, no. 41, pp. 10270–10277, 2012. View at Publisher · View at Google Scholar · View at Scopus
  114. W. Huang, Z. Chen, Q. Wang et al., “Piperine potentiates the antidepressant-like effect of trans-resveratrol: involvement of monoaminergic system,” Metabolic Brain Disease, vol. 28, no. 4, pp. 585–595, 2013. View at Publisher · View at Google Scholar · View at Scopus
  115. A. I. Oliveira, C. Pinho, B. Sarmento, and A. C. P. Dias, “Neuroprotective activity of Hypericum perforatum and its major components,” Frontiers in Plant Science, vol. 7, 2016. View at Publisher · View at Google Scholar · View at Scopus
  116. S. D. S. Banjarnahor and N. Artanti, “Antioxidant properties of flavonoids,” Medical Journal of Indonesia, vol. 23, no. 4, p. 239, 2015. View at Publisher · View at Google Scholar
  117. S. R. K. M. Hewage, M. J. Piao, K. A. Kang et al., “Hesperidin attenuates ultraviolet B-induced apoptosis by mitigating oxidative stress in human keratinocytes,” Biomolecules & Therapeutics, vol. 24, no. 3, pp. 312–319, 2016. View at Publisher · View at Google Scholar · View at Scopus
  118. C. Zhu, Y. Dong, H. Liu, H. Ren, and Z. Cui, “Hesperetin protects against H2O2-triggered oxidative damage via upregulation of the Keap1-Nrf2/HO-1 signal pathway in ARPE-19 cells,” Biomedicine & Pharmacotherapy, vol. 88, pp. 124–133, 2017. View at Publisher · View at Google Scholar
  119. P. S. Arwa, M. L. Zeraik, V. F. Ximenes, L. M. da Fonseca, V. da Silva Bolzani, and D. H. S. Silva, “Redox-active biflavonoids from Garcinia brasiliensis as inhibitors of neutrophil oxidative burst and human erythrocyte membrane damage,” Journal of Ethnopharmacology, vol. 174, pp. 410–418, 2015. View at Publisher · View at Google Scholar · View at Scopus
  120. E. J. Jeong, L. Hwang, M. Lee, K. Y. Lee, M. J. Ahn, and S. H. Sung, “Neuroprotective biflavonoids of Chamaecyparis obtusa leaves against glutamate-induced oxidative stress in HT22 hippocampal cells,” Food and Chemical Toxicology, vol. 64, pp. 397–402, 2014. View at Publisher · View at Google Scholar · View at Scopus
  121. L. Chen, B. Zhang, S. Shan, and X. Zhao, “Neuroprotective effects of vitexin against isoflurane-induced neurotoxicity by targeting the TRPV1 and NR2B signaling pathways,” Molecular Medicine Reports, vol. 14, no. 6, pp. 5607–5613, 2016. View at Publisher · View at Google Scholar · View at Scopus
  122. C. S. Huang, C. K. Lii, A. H. Lin et al., “Protection by chrysin, apigenin, and luteolin against oxidative stress is mediated by the Nrf2-dependent up-regulation of heme oxygenase 1 and glutamate cysteine ligase in rat primary hepatocytes,” Archives of Toxicology, vol. 87, no. 1, pp. 167–178, 2013. View at Publisher · View at Google Scholar · View at Scopus
  123. Y. Chtourou, A. B. Slima, R. Gdoura, and H. Fetoui, “Naringenin mitigates iron-induced anxiety-like behavioral impairment, mitochondrial dysfunctions, ectonucleotidases and acetylcholinesterase alteration activities in rat hippocampus,” Neurochemical Research, vol. 40, no. 8, pp. 1563–1575, 2015. View at Publisher · View at Google Scholar · View at Scopus
  124. H. P. Ma, X. N. Ma, B. F. Ge et al., “Icariin attenuates hypoxia-induced oxidative stress and apoptosis in osteoblasts and preserves their osteogenic differentiation potential in vitro,” Cell Proliferation, vol. 47, no. 6, pp. 527–539, 2014. View at Publisher · View at Google Scholar · View at Scopus
  125. B. Wang, Q. Zhang, R. Yao, X. Liu, and Z. Qu, “7, 8-Dihydroxyflavone protects an endothelial cell line from H2O2 damage,” PLoS One, vol. 10, no. 8, article e0135345, 2015. View at Publisher · View at Google Scholar · View at Scopus
  126. X. L. Hao, Y. Kang, J. K. Li, Q. S. Li, E. L. Liu, and X. X. Liu, “Protective effects of hyperoside against H2O2-induced apoptosis in human umbilical vein endothelial cells,” Molecular Medicine Reports, vol. 14, no. 1, pp. 399–405, 2016. View at Publisher · View at Google Scholar · View at Scopus
  127. E. O. Choi, J. W. Jeong, C. Park et al., “Baicalein protects C6 glial cells against hydrogen peroxide-induced oxidative stress and apoptosis through regulation of the Nrf2 signaling pathway,” International Journal of Molecular Medicine, vol. 37, no. 3, pp. 798–806, 2016. View at Publisher · View at Google Scholar · View at Scopus
  128. M. M. J. P. E. Sthijns, P. M. Schiffers, G. M. Janssen et al., “Rutin protects against H2O2-triggered impaired relaxation of placental arterioles and induces Nrf2-mediated adaptation in human umbilical vein endothelial cells exposed to oxidative stress,” Biochimica et Biophysica Acta (BBA) - General Subjects, vol. 1861, no. 5, pp. 1177–1189, 2017. View at Publisher · View at Google Scholar
  129. H. Chang, C. Li, K. Huo et al., “Luteolin prevents H2O2-induced apoptosis in H9C2 cells through modulating Akt-P53/Mdm2 signaling pathway,” BioMed Research International, vol. 2016, Article ID 5125836, 9 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  130. J. H. Yen, P. S. Wu, S. F. Chen, and M. J. Wu, “Fisetin protects PC12 cells from tunicamycin-mediated cell death via reactive oxygen species scavenging and modulation of Nrf2-driven gene expression, SIRT1 and MAPK signaling in PC12 cells,” International Journal of Molecular Sciences, vol. 18, no. 4, p. 852, 2017. View at Publisher · View at Google Scholar
  131. A. Murakami and H. Ohigashi, “Cancer-preventive anti-oxidants that attenuate free radical generation by inflammatory cells,” Biological Chemistry, vol. 387, no. 4, pp. 387–392, 2006. View at Publisher · View at Google Scholar · View at Scopus
  132. J. C. R. Vellosa, L. O. Regasini, C. Belló et al., “Preliminary in vitro and ex vivo evaluation of afzelin, kaempferitrin and pterogynoside action over free radicals and reactive oxygen species,” Archives of Pharmacal Research, vol. 38, no. 6, pp. 1168–1177, 2015. View at Publisher · View at Google Scholar · View at Scopus
  133. D. Bao, J. Wang, X. Pang, and H. Liu, “Protective effect of quercetin against oxidative stress-induced cytotoxicity in rat pheochromocytoma (PC-12) cells,” Molecules, vol. 22, no. 7, p. 1122, 2017. View at Publisher · View at Google Scholar
  134. J. Liu, X. Li, J. Lin et al., “Sarcandra glabra (Caoshanhu) protects mesenchymal stem cells from oxidative stress: a bioevaluation and mechanistic chemistry,” BMC Complementary and Alternative Medicine, vol. 16, no. 1, p. 423, 2016. View at Publisher · View at Google Scholar · View at Scopus
  135. A. Primikyri, G. Mazzone, C. Lekka, A. G. Tzakos, N. Russo, and I. P. Gerothanassis, “Understanding zinc(II) chelation with quercetin and luteolin: a combined NMR and theoretical study,” The Journal of Physical Chemistry B, vol. 119, no. 1, pp. 83–95, 2015. View at Publisher · View at Google Scholar · View at Scopus
  136. M. N. I. Bhuiyan, S. Mitsuhashi, K. Sigetomi, and M. Ubukata, “Quercetin inhibits advanced glycation end product formation via chelating metal ions, trapping methylglyoxal, and trapping reactive oxygen species,” Bioscience, Biotechnology, and Biochemistry, vol. 81, no. 5, pp. 882–890, 2017. View at Publisher · View at Google Scholar
  137. F. Alam, Q. N. Saqib, and M. Ashraf, “Gaultheria trichophylla (Royle): a source of minerals and biologically active molecules, its antioxidant and anti-lipoxygenase activities,” BMC Complementary and Alternative Medicine, vol. 17, no. 1, p. 3, 2017. View at Publisher · View at Google Scholar
  138. H. Cao, J. M. Pauff, and R. Hille, “X-ray crystal structure of a xanthine oxidase complex with the flavonoid inhibitor quercetin,” Journal of Natural Products, vol. 77, no. 7, pp. 1693–1699, 2014. View at Publisher · View at Google Scholar · View at Scopus
  139. H. Cao, B. Chen, Y. Deng, X. Lu, and G. Yu, “Baicalin increases the antioxidant capacity via promoting the nuclear translocation of NF-E2-related factor 2 (Nrf2) in N2a/APPswe cells,” Chinese Journal of Cellular and Molecular Immunology, vol. 31, no. 12, pp. 1597–1601, 2015. View at Google Scholar
  140. K. Kaltalioglu and S. Coskun-Cevher, “Potential of morin and hesperidin in the prevention of cisplatin-induced nephrotoxicity,” Renal Failure, vol. 38, no. 8, pp. 1291–1299, 2016. View at Publisher · View at Google Scholar · View at Scopus
  141. L. N. Bodduluru, E. R. Kasala, R. M. Madhana et al., “Naringenin ameliorates inflammation and cell proliferation in benzo(a)pyrene induced pulmonary carcinogenesis by modulating CYP1A1, NFκB and PCNA expression,” International Immunopharmacology, vol. 30, pp. 102–110, 2016. View at Publisher · View at Google Scholar · View at Scopus
  142. S. Kim, Y. W. Chin, and J. Cho, “Protection of cultured cortical neurons by luteolin against oxidative damage through inhibition of apoptosis and induction of heme oxygenase-1,” Biological and Pharmaceutical Bulletin, vol. 40, no. 3, pp. 256–265, 2017. View at Publisher · View at Google Scholar
  143. R. Kabirifar, Z. Ghoreshi, F. Safari, A. Karimollah, A. Moradi, and E. Eskandari-Nasab, “Quercetin protects liver injury induced by bile duct ligation via attenuation of Rac1 and NADPH oxidase1 expression in rats,” Hepatobiliary & Pancreatic Diseases International, vol. 16, no. 1, pp. 88–95, 2017. View at Publisher · View at Google Scholar
  144. H. Ihara, H. Yamamoto, T. Ida et al., “Inhibition of nitric oxide production and inducible nitric oxide synthase expression by a polymethoxyflavone from young fruits of Citrus unshiu in rat primary astrocytes,” Bioscience, Biotechnology, and Biochemistry, vol. 76, no. 10, pp. 1843–1848, 2012. View at Publisher · View at Google Scholar · View at Scopus
  145. W. N. Marsden, “Synaptic plasticity in depression: molecular, cellular and functional correlates,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 43, pp. 168–184, 2013. View at Publisher · View at Google Scholar · View at Scopus
  146. M. Banasr, J. M. Dwyer, and R. S. Duman, “Cell atrophy and loss in depression: reversal by antidepressant treatment,” Current Opinion in Cell Biology, vol. 23, no. 6, pp. 730–737, 2011. View at Publisher · View at Google Scholar · View at Scopus
  147. A. Sawamoto, S. Okuyama, Y. Amakura et al., “3,5,6,7,8,3,4-Heptamethoxyflavone ameliorates depressive-like behavior and hippocampal neurochemical changes in chronic unpredictable mild stressed mice by regulating the brain-derived neurotrophic factor: requirement for ERK activation,” International Journal of Molecular Sciences, vol. 18, no. 10, p. 2133, 2017. View at Publisher · View at Google Scholar
  148. M. Shirai, Y. Kawai, R. Yamanishi, and J. Terao, “Approach to novel functional foods for stress control 5. Antioxidant activity profiles of antidepressant herbs and their active components,” The Journal of Medical Investigation, vol. 52, Supplement, pp. 249–251, 2005. View at Publisher · View at Google Scholar · View at Scopus
  149. S. Carradori, M. C. Gidaro, A. Petzer et al., “Inhibition of human monoamine oxidase: biological and molecular modeling studies on selected natural flavonoids,” Journal of Agricultural and Food Chemistry, vol. 64, no. 47, pp. 9004–9011, 2016. View at Publisher · View at Google Scholar · View at Scopus
  150. R. Pingili, S. Vemulapalli, S. S. Mullapudi, S. Nuthakki, S. Pendyala, and N. Kilaru, “Pharmacokinetic interaction study between flavanones (hesperetin, naringenin) and rasagiline mesylate in wistar rats,” Drug Development and Industrial Pharmacy, vol. 42, no. 7, pp. 1110–1117, 2016. View at Publisher · View at Google Scholar · View at Scopus
  151. L. H. Martini, F. Jung, F. A. Soares et al., “Naturally occurring compounds affect glutamatergic neurotransmission in rat brain,” Neurochemical Research, vol. 32, no. 11, pp. 1950–1956, 2007. View at Publisher · View at Google Scholar · View at Scopus